Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Aficamten's trials
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
Aficamten
Completed
Completed
Phase 3
Open NCT06116968 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT06116968 · Trial Tracker · ComplyRx
